← Open Payments lookup

JOHN SCHILTZ: Open Payments

NPI 1154533107 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$829 in 7 payments from 6 companies in 2025. Trend: 2023 $240 · 2024 $748 · 2025 $829

Food & beverage: $829
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.2$226
E.R. Squibb & Sons, L.L.C.1$133
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$126
Otsuka America Pharmaceutical, Inc.1$125
Axsome Therapeutics, Inc.1$118
Supernus Pharmaceuticals, Inc.1$100

Products named: FANAPT, COBENFY, CAPLYTA, REXULTI, Auvelity, Qelbree.

Industry payments across IN — which companies pay providers there.